Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathway by Chirico, William J
RESEARCH ARTICLE Open Access
Protein release through nonlethal oncotic pores
as an alternative nonclassical secretory pathway
William J Chirico
Abstract
Background: Nonclassical (unconventional) protein secretion is thought to represent the primary secretion
mechanism for several cytosolic proteins, such as HIV-Tat, galectin 1, interleukin-1b, and several proteins that
shuttle between the nucleus and cytosol, such as fibroblast growth factor 1 (FGF1), FGF2, and nucleolin. Four
nonclassical secretory pathways have been described including direct transport (presumably through transporters
in the plasma membrane), secretion via exosomes, lysosomal secretion, and blebbing. The purpose of this study
was to gain mechanistic insight into nonclassical protein secretion using phosphoglycerate kinase 1 (PGK1), a
previously identified nonclassical secretory protein, as a reporter protein.
Results: Upon shifting HeLa cells into serum-free media PGK1 was released as a free soluble protein without cell
loss. Release occurred in two phases: a rapid early phase and a slow late phase. Using a repertory of inhibitors,
PGK1 release was shown not to rely on the classical secretory pathway. However, components of the cytoskeleton
partially contributed to its release. Significantly, the presence of serum or bovine serum albumin in the media
inhibited PGK1 release.
Conclusions: These results are consistent with a novel model of protein release termed oncotic release, in which a
change in the colloidal osmotic pressure (oncotic pressure) upon serum withdrawal creates nonlethal oncotic
pores in the plasma membrane through which PGK1 - and likely other nearby proteins - are released before the
pores are rapidly resealed. These findings identify an alternative mechanism of release for FGF1, HIV-Tat, and
galectin 1 whose reported nonclassical secretion is induced by serum withdrawal. Oncotic release may occur in
routine cell biological experiments during which cells are washed with serum-free buffers or media and in
pathophysiological conditions, such as edema, during which extracellular protein concentrations change.
Background
Several important proteins, such fibroblast growth factor
1 (FGF1), FGF2, and interleukin-1b (IL-1b) are secreted
from cells by alternative pathways collectively termed
nonclassical (unconventional) secretory pathways [1].
Nonclassical secretory proteins are not synthesized as
precursors with an N-terminal hydrophobic signal
sequence, which is common to classical secretory pro-
teins, and they are not glycosylated. They do not use the
endoplasmic reticulum and Golgi apparatus as conduits
to the cell surface and their secretion is resistant to bre-
feldin A (BFA), a potent inhibitor of the classical secre-
tory pathway.
Four nonclassical protein secretory pathways have
been described (reviewed in [2]). They include 1) direct
transport of proteins from the cytosol across the plasma
membrane presumably through membrane transporters,
2) lysosomal secretion, 3) export via exosomes derived
from multivesicular bodies, and 4) packaging of proteins
into plasma membrane vesicles (blebbing). In addition,
cytosolic proteins can exit cells damaged by mechanical
means, such as scraping and needle puncture [3].
Although FGF1 and FGF2 can be secreted directly
through the plasma membrane, the dependence of
FGF1, but not FGF2, secretion on heat shock suggests
they are secreted by different mechanisms [4]. Some
proteins can leave by more than one pathway depending
on cell type or experimental conditions. For example,
IL-1b can be exported in secretory lysosomes [5], blebs
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brane by unknown transporters [8].
In experiments described in this report, an established
nonclassical secretory protein, phosphoglycerate kinase
1 (PGK1), was used to gain insight into the mechanism
of nonclassical protein secretion. PGK1 is the sixth
enzyme in glycolysis catalyzing the conversion of 1,3
bisphosphoglycerate into 3-phosphoglycerate and yield-
ing ATP. Extracellular PGK1 acts as a disulphide reduc-
tase in an enzymatic cascade generating angiostatin
from plasmin [9]. PGK1 is an abundant cytosolic protein
and its biochemical and structural properties are well
established rendering it an excellent model protein to
study nonclassical protein secretion [10]. In contrast,
many nonclassically secreted proteins, such as FGF1 and
FGF2, are found in trace amounts in cells necessitating
their overexpression for analysis.
PGK1 can be released from a variety of cells including
HeLa [9,11]. It is reported here that PGK1 can be
rapidly released from HeLa cells by lowering the colloi-
dal osmotic pressure (oncotic pressure) of the media, a
procedure routinely used in cell biology when cells are
washed with isoosmotic solutions, such as serum-free
media or phosphate buffered saline (PBS). PGK1 exits at
discreet sites of disrupted plasma membrane (oncotic
pores) without catastrophic cell loss. This process is
termed oncotic release.
Results
PGK1 as reporter for nonclassical secretion
Hogg and coworkers previously demonstrated that
PGK1 can be released from a variety of cells lines
including HT1080 cells [9]. PGK1 is an excellent model
protein to study nonclassical protein secretion because
it is abundant and has several hallmarks of nonclassi-
cally secreted proteins. An ELISA assay was used to
quantify intracellular and extracellular pools of PGK1
[11]. Immunoblots indicated that PGK1 in both pools is
very stable with negligible fragmentation ([11], data not
shown). HeLa cells were used as a model system,
because they are routinely used in the laboratory and
the amount of PGK1 released from them [11] and
HT1080 cells [9] were comparable.
Cell density affects PGK1 release
During the optimization of the PGK1 release assay it
was noticed that release was less efficient in more con-
fluent cultures. To determine the effect of cell density
on PGK1 release HeLa cells were plated at different
densities, allowed to grow for 24 h, and then the
amount of PGK1 released into serum-free media during
a 2-h incubation was measured. Although PGK1 was
released at all cell densities tested, the efficiency of
release on a per cell basis was maximal at 40,000 cells/
well (Figure 1). This result suggested that cell-cell inter-
actions attenuate PGK1 release and established 40,000
cells/well (21,000 cells/cm
2) as the optimal cell density
for the experiments.
Time course of PGK1 release
To gain insight into the release process, the time
course of PGK1 release from HeLa cells into serum-
free medium was measured (Figure 2A). LDH activity
was measured to monitor cytotoxicity. Although PGK1
and LDH were released from cells in two phases: a
rapid early phase (<30 min) and a slow later phase
(30-240 min), the extent of release was different.
About 7.5% of the amount of cellular PGK1 at the
beginning of the experiment was detected in the media
by 7.5 min. By 30 min, the amount of PGK1 in the
media decreased to about 4% (P < 0.05). In the slow
second phase, the amount of PGK in the media gradu-
ally increased from 4% to about 7% (P < 0.05). In con-
trast, about 16% of the amount of LDH in the cell at
the beginning of the experiment was released by 7.5
min and this amount decreased to 12% by 30 min (P <
0.05). The amount of LDH in the media then increased
slightly to 13% (P < 0.05) by 240 min. These results
suggest that PGK1 and LDH can be released rapidly
into serum-free media and that some of the extracellu-
lar PGK1 and LDH can be degraded or rendered unde-
tectable to their respective assays.
0
50
100
150
200
250
P
G
K
1
R
e
l
e
a
s
e
d
(
A
U
p
e
r
1
0
0
0
c
e
l
l
s
)
0 50 100 150 200
Cell Number (x1 0 -3)
Figure 1 Effect of cell density on PGK1 release. HeLa cells were
plated at the indicated cell densities in MEM/10% NBS. After 24 h,
the cells were washed with serum-free MEM and then incubated
with the same media for 2 h. The amount of PGK1 released into the
media was determined using an ELISA. Error bars represent the s.d.
of the mean (n = 4). AU, arbitrary units.
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media did not equal the amount of PGK1 lost from the
cell (Figure 2B). The amount of cellular PGK1 rapidly
decreased to 60% of the original concentration during
the first 30 min and then gradually decreased to 40% by
240 min (P < 0.05, Figure 2B). The sudden decrease in
the amount of PGK1 in the cell may result from its
rapid release, degradation within the cell, or both upon
shifting the cells into serum-free media. In contrast, the
amount of LDH in the cell decreased to 75% of the ori-
ginal amount by 7.5 min (P < 0.05). By 30 min, the
cellular LDH concentration recovered to about 85% (P <
0.05) of the original amount suggesting that some LDH
was reabsorbed or replenished by the cell. The concen-
tration of LDH in the cell, in contrast to that of PGK1,
was relatively constant at about 80% of the original
amount between 30 and 240 min.
To test the possibility that PGK1 and LDH release
accompanied catastrophic cell loss, the number of cells
(based on DNA content) remaining after transferring
them into serum-free media was measured (Figure 3).
The number of cells remained essentially unchanged
after 1 h, a point at which the cellular concentration of
PGK1 and LDH decreased, respectively, by 40% and
20%. In contrast, 75% of cells were lost after treating
them with water presumably due to hypoosmotic swel-
ling and lysis. This result supports the idea that cata-
strophic cell loss does not accompany PGK1 and LDH
release.
Vesicle-independent release of PGK1
Some nonclassically secreted proteins are packaged into
vesicles before or during their release from cells. For
example, galectin 3 has been localized in membrane
blebs [12] and under certain conditions IL-1b [7] can be
found in exosomes. To test the hypothesis that PGK1 is
released in vesicles a protease protection assay was per-
formed (Figure 4). In this assay, a protein is protected
0
5
10
15
20
R
e
l
e
a
s
e
d
(
%
)
0
25
50
75
100
125
A
m
o
u
n
t
i
n
C
e
l
l
L
y
s
a
t
e
(
%
)
0 50 100 150 200 250
Time (min)
B
PGK1
LDH
PGK1
LDH
A
Figure 2 Time course of PGK1 release.A f t e rH e L ac e l l sw e r e
grown in MEM/10% NBS for 24 h, the cells were washed once with
serum-free MEM and then incubated in the same media for the
indicated times. The amount of PGK1 and LDH released (A) and
remaining in cell lysates (B) was determined and expressed as a
percent of the total of each protein in cell lysates at 0 min
(untreated cells). Error bars represent the s.d. of the mean (n = 4).
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Figure 3 Cell loss does not accompany serum-withdrawal.
HeLa cells were grown for 24 h in MEM/10% NCS and then either
left untreated (NT) or washed once with serum-free MEM and
then incubated in the same media for 1 h (MEM). A parallel set of
samples was treated with water (Water). Cell number was assayed
using SYTOX Green and expressed as the percent remaining
relative to the untreated sample. Error bars represent the s.d. of
t h em e a n( n=4 ) .
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within a membrane vesicle. Released PGK1 was comple-
tely digested with Proteinase K in the presence (lane 4)
or absence (lane 2) of a Triton X-100. Untreated PGK1
was stable in the presence (lane 3) or absence (lane 1)
of the detergent. Together these results indicate that
PGK1 is released as a free soluble protein and not pro-
tected within a vesicle.
Effect of various inhibitors on PGK1 release
To test the hypothesis that PGK1 is released through a
nonclassical secretory pathway its release in the pre-
sence of brefeldin A (BFA) or Exo1 was monitored. BFA
blocks the classical secretory pathway by inhibiting Arf1,
a GTP-binding protein required to initiate bud forma-
tion (reviewed in [13]). Although the mechanism by
which Exo1 inhibits the classical secretory pathway is
not completely understood, it likely interferes with the
formation of Arf1-containing complexes involved in ER
to Golgi transport [14]. BFA inhibited PGK1 and LDH
r e l e a s eb y2 7a n d2 0 % ,r e s p e c t i v e l y( T a b l e1 ) .I nc o n -
trast, the secretion of prolactin, which is a protein that
passes through the classical secretory pathway, was
blocked greater than 90% in the presence of BFA (data
not shown, [15]). Interestingly, Exo1 did not significantly
affect PGK1 or LDH release (Table 1). Together these
results suggest that PGK1 and LDH release are similar
and that the classical secretory pathway has a minor
role in their release.
ATP binding cassette (ABC) transporters have been
shown to play a role in the nonclassical secretion of
IL-1b [16]. Glyburide, an inhibitor of the ABC1 trans-
porter, was used to probe its contribution, if any, to
PGK1 release. Glyburide inhibited PGK1 and LDH
release by 24 and 20%, respectively, suggesting that
ABC transporters contribute fractionally to their
release (Table 1).
Cytochalasin D, an inhibitor of actin polymerization,
inhibited PGK1 and LDH release by 31 and 37%, respec-
tively (Table 1). Similarly, nocodazole, an inhibitor of
microtubule polymerization, inhibited PGK1 and LDH
release by 39 and 34%, respectively (Table 1). Together
these results support the idea that PGK1 and LDH are
released from cells by a pathway dependent, in part, on
the actin and microtubule components of the
cytoskeleton.
P K -+-+
Triton - - + +
4 3 2 1
Figure 4 PGK1 released as a free soluble protein. Media was collected from HeLa cell cultures 7.5 min after serum withdrawal and then
treated with (lanes 2 and 4) or without Proteinase K (PK, lanes 1 and 3) in the presence (lanes 3 and 4) or absence (lanes 1 and 2) of Triton X-
100 (Triton) as described in Materials and Methods. Samples were separated on SDS-PAGE gels and then immunoblotted with anti-PGK1
antibodies.
Table 1 Change in the amount of PGK1 and LDH in media and cell lysates after treating HeLa cells with various
reagents
Reagent Percent change within each compartment relative to vehicle (n = 4)
PGK1 LDH
Media Cell Media Cell
BFA -27 ± 8 NS -20 ± 10 NS
Exo1 NS NS NS -16 ± 4
Glyburide -24 ± 11 NS -20 ± 8 NS
Cytochalasin D -31 ± 9 10 ± 9 -37 ± 2 6 ± 5
Nocodazole -39 ± 12 NS -34 ± 6 NS
NS, no significant change
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pathways were also examined (Additional file 1, Table
S1). The inhibitors included methylamine (inhibitor of
endosomal and lysosomal function), ouabain (inhibitor
of the Na
+,K
+-ATPase pump), calcimycin (membrane
permeable Ca
2+ ionophore), and EGTA (membrane
impermeable Ca
2+ chelator). In each case, the inhibition
of PGK1 release was either negligible or may have
resulted from the inhibitor-induced loss of cytosolic
PGK1 (Additional file 1, Table S1).
Serum or BSA blocks PGK1 release
Serum was previously shown to affect the secretion of
some nonclassically secreted proteins. For example,
serum withdrawal stimulated secretion of FGF1 [17,18]
and HIV-1 Tat protein [19], but inhibited secretion of
FGF2 [20] and IL-1b [21]. To gain insight into the role
of serum in regulating PGK1 release the amount of
PGK1 released at different concentrations of serum was
measured. The amount of PGK1 released was inversely
proportional to serum concentration (Figure 5A). This
result indicated that serum attenuates PGK1 release and
suggests that the release pathways of FGF1 [17], Tat
[19] and PGK1 are, in part, similar.
The findings thus far demonstrate that PGK1 is
rapidly released from cells through a process stimulated
by serum withdrawal. Two possible explanations for
serum regulation of nonclassical secretion were consid-
ered. First, the loss of growth factors or cytokines
accompanying the shift to serum-free conditions might
act as a specific signal for secretion. Second, the loss of
total protein from media might act nonspecifically to
promote secretion. To distinguish these two possibilities,
the effect of different concentrations of BSA on PGK1
release was measured. BSA, like serum, attenuated
PGK1 release (Figure 5B). Interestingly the lowest con-
centration of BSA required to block PGK1 release was 6
mg/ml - about the same concentration as that of total
protein in the culture medium (MEM/10% serum). This
result supports the idea that changing the total protein
concentration in the media influences PGK1 release.
Confocal microscopy of PGK1 release
The results suggest that transferring HeLa cells into
serum-free media induces the rapid release of PGK1. To
identify the site(s) of PGK release the appearance of
PGK1 on the cell surface upon shifting cells into serum-
free media was monitored using confocal microscopy.
To detect PGK1 appearing only on the cell surface the
cells were not permeabilized with detergent. Plumes of
PGK1 were detected on the surface of cells transferred
into serum-free media (Figure 6, panels d-f). In contrast,
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Figure 5 Serum or BSA blocks release of PGK1 and LDH.
HeLa cells were grown for 24 h in MEM containing 10% serum.
After 24 h, media was removed, the cells washed with MEM
containing the indicated amounts of serum (A)o rB S A( B), and
then incubated with the same media for 7.5 min. The media was
collected and the amount of PGK1 and LDH was quantified as
described in Materials and Methods. Values are expressed as the
ratio of the amount of each protein in the media at each
concentration of serum or BSA relative to that in the absence of
serum or BSA, respectively. For graphing purposes, the sample
lacking serum was defined as 0.001% serum and that lacking BSA
as 0.01 mg/ml BSA. Error bars represent the s.d. of the mean
(n = 4).
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Page 5 of 11the amount of PGK1 released from untreated cells (Fig-
ure 6, panels a-c) or cells transferred into serum-free
media containing BSA (Figure 6, panels g-i) was negligi-
ble. These results support the idea that PGK1 is released
from intact cells at one or more sites.
Entry of a membrane impermeable probe under serum-
free conditions
SYTOX Green, which is a membrane impermeable
fluorescent dye, was used to test the possibility that sites
of PGK1 release may permit entry of material into the
cell. HeLa cells were incubated for 10 min with SYTOX
Green in serum-free or BSA-containing media and the
amount of cell-associated fluorescence was measured.
About 11-fold more fluorescence was associated with
cells incubated with serum-free media than with BSA-
containing media (Additional file 2, Figure S1). This
result is consistent with the idea that transient sites on
t h ep l a s m am e m b r a n eo p e ni nr e s p o n s et ot h ea c u t e
decrease in extracellular protein concentration allowing
Figure 6 Confocal images of PGK1 at the cell surface. HeLa cells were grown in MEM supplemented with 10% NBS. After 24 h, they were
either left untreated (a-c), washed once with serum-free MEM and then incubated with the same media for 30 min (d-f), or washed once with
serum-free MEM containing BSA and then incubated with the same media for 30 min (g-i). After the incubations the cells were fixed as
described in Materials and Methods. Cells were not permeabilized with detergents in order to detect only cell surface proteins. The cell surface
was detected using wheat germ agglutinin (WGA, red) and PGK1 (green) was localized using affinity purified rabbit anti-human PGK1 antibody.
The bar represents 10 μm (i).
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reagents, such as SYTOX Green, to enter.
Discussion
In this study PGK1 was used to investigate mechanisms
of nonclassical protein secretion. At least 4 models of
nonclassical secretion have been proposed including 1)
direct passage through a membrane transporter, 2) lyso-
somal secretion, 3) secretion in exosomes, and 4) bleb-
bing (reviewed in [2]). In addition, mechanically
wounding the plasma membrane by scraping can release
cytosolic proteins, such as FGF2 [3].
The results presented herein lead to a working model
of protein release in which nonlethal oncotic pores or
microruptures are formed in the plasma membrane in
r e s p o n s et ot h ec h a n g ei nc o l l o i d a lo s m o t i cp r e s s u r e
upon serum withdrawal allowing the release of PGK1
(and other proteins, for example, LDH) before the pores
are rapidly resealed.
Central to the working model of protein release
through oncotic pores are the findings that PGK1
release was induced by serum withdrawal and that BSA
prevented it. This suggests that its release is triggered by
t h ec h a n g ei nc o l l o i d a lo s m o t i cp r e s s u r e( o n c o t i cp r e s -
sure) instead of a specific factor present in serum.
Changes in osmolarity of cell culture media have been
demonstrated to alter cell morphology (reviewed in
[22]). For example, hyperosmolar solutions shrink cells
and hypoosmolar solutions swell cells. The possibility
that serum was affecting the osmolarity of the media
was excluded by the finding that MEM with or without
10% newborn calf serum had an osmolarity of 320 ± 10
mOsm. Protein solutions, however, have a colligative
property that can create a potential energy difference
across a semipermeable membrane, such as the cell
membrane [23]. This energy difference is termed onco-
tic pressure or colloidal osmotic pressure [24].
In addition to PGK1, several nonclassically secreted
proteins, such as FGF1 [17,18,25,26], S100A13 [17], Tat
[19], and galectin 1 [27], are released from cells upon
serum withdrawal. A mutated version of rhodanese,
which lacked its mitochondrial targeting sequence, was
rapidly released from HEK293 cells upon serum with-
drawal without any appreciable cell death [28]. Thus,
withdrawing or lowering the concentration of serum in
media can induce the release of certain proteins by
incompletely understood mechanisms.
On the other hand, nonclassical secretory proteins,
such as L-29 lectin (galectin-3) [29] and FGF2, under
certain conditions [30], can be secreted in the presence
of serum. An early report [31] showed FGF2 was
released from endothelial cells into serum-free condi-
tioned media while another [20] showed FGF2 secretion
from NIH 3T3 cells required serum and serum-free
conditions blocked its secretion. Raising the concentra-
tion of fetal bovine serum increased the secretion of
FGF2 from AIDS-KS cells [32]. Brooks et al. [33]
showed that FGF2 can be released from bovine retinal
endothelial cells in the presence or absence of serum.
Release correlated with cell damage but only after pro-
longed incubation ranging from 24 to 96 h [33]. These
disparate findings likely represent the ability of FGF2 to
exit cells by different routes under different experimen-
tal conditions.
The above working model of protein release through
oncotic pores is consistent with the time course of
PGK1 release, cell viability during release, and the effect
of cell density on release. The rapid release of PGK1
during the first 30 min may reflect the formation of the
pores/microruptures, whereas the attenuation of release
may reflect the resealing of the membrane. Catastrophic
cell loss did not accompany the release of PGK1 during
the formation and subsequent resealing of the plasma
membrane. PGK1 release was more efficient at low cell
density suggesting that fewer intercellular contacts or
more exposed cell surface promote oncotic release.
A variety of inhibitors of classical and nonclassical
secretion was used to gain insight into the mechanism
of PGK1 release. Resistance of a protein’s secretion to
inhibitors of the classical secretory pathway, such as
BFA, is the hallmark of nonclassical protein secretion
[1]. The effect of BFA and Exo1 on PGK1 release was
complex - BFA inhibited release by 27%, whereas Exo1
had no significant effect. A comparison of the mechan-
ism of inhibition of BFA and Exo1 suggests that Exo1’s
effects may be more localized to the Golgi apparatus,
whereas those of BFA may be pleiotropic [14,34,35]. For
example, BFA, but not Exo1, induces tubulation and
collapse of the trans Golgi network and endosomes [14].
And, BFA promotes the release of broader spectrum of
proteins from the Golgi than does Exo1 [14,34]. Finally,
BFA, but not Exo1, induces the inhibition of CtBP/
Bars50, which catalyzes the transfer of palmitate from
palmitoyl CoA to lysophosphatidic acid and regulates
fission of vesicles from the TGN and plasma membrane
[35]. Perhaps inhibiting CtBP/Bars50 influences plasma
membrane integrity thereby limiting PGK1 and LDH
release during oncotic challenge.
The mechanism by which ABC transporters promote
nonclassical protein secretion remains unknown, how-
ever, others have suggested they directly transport pro-
teins through their channels or indirectly affect
transport during “flipping” of phosphatidylserine
[16,36-38]. The partial inhibition of PGK1 release by
glyburide raises the possibility that the ion transport
activity of some ABC transporters contributes to oncotic
damage by allowing cells to swell and oncotic pores/
microruptures to form during serum-withdrawal.
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transporter-dependent swelling. Indeed, glyburide has
been used to reduce swelling in cerebral edema by inhi-
biting a nonselective cation channel [39].
Cytochalasin D and nocodazole inhibited PGK1 and
LDH release by 30-40% (Table 1) suggesting their
release, in part, relies on actin and microtubules. The
actin cytoskeleton has been shown to contribute to the
nonclassical secretion of FGF1 [17,26] and sphingosine
kinase [40]. The microtubule network contributes to
galectin 3 nonclassical secretion [41]. Walsh et al. [42]
showed that PGK1, LDH and other proteins associate
with microtubules. Thus it is possible that the cytoskele-
ton aids the trafficking or localization of some nonclas-
sically secreted proteins and PGK1 to the plasma
membrane and oncotic pores.
The above working model of protein release through
oncotic pores accommodates features of nonclassically
secreted proteins not addressed directly in this study,
such as conformation, charge, and diffusion-limited
release. Passage through a large oncotic pore/microrup-
ture would obviate the necessity of protein unfolding
during transport. Indeed, neither FGF1 [43] nor FGF2
[44] unfold during secretion. The model offers an expla-
nation for the observation that many, but not all, non-
classically secreted proteins have basic isoelectric points.
For example, galectin-3, thioredoxin, FGF2, LDH-A, and
PGK1 have pIs of 9.0, 8.9, 9.2, 8.4 and 8.3, respectively.
FGF1’s pI is 5.2, but its secretion is dependent on its
interaction with S100A13 [45], which has a pI of 8.35. A
protein’s basic isoelectric point may facilitate its interac-
tion with the negatively charged phospholipids of the
inner leaflet on the plasma membrane before and during
passage through oncotic pores. In addition, the oncotic
potential generated by negatively charged serum pro-
teins, such as albumin (pI of 4.7), might draw positively
charged cytosolic proteins towards the membrane.
Lastly, secretion of some nonclassically secreted pro-
teins, such as FGF2, either by mechanical injury to the
cell membrane [46] or by other routes [2] is diffusion
controlled. Passage through an oncotic pore/microrup-
ture would likely be rapid.
Although PGK1 can be released through oncotic
pores, the possibility remains that it can be released
through other routes depending on conditions or cell
type. For example, IL-1b can leave cells by plasma mem-
brane shedding, in exosomes derived from multivesicu-
lar bodies, or through lysosomal secretion [47]. And
FGF2 can be released in vesicles shed from cells [30] or
directly through the plasma membrane [48,49].
Release of proteins through oncotic pores and subse-
quent membrane repair may occur in pathophysiological
conditions such as edema, ischemia, and inflammation
during which oncotic pressure can change. The presence
of PGK1 in serum may serve as an early indicator of
plasma membrane damage. In experimental cell biology,
cytosolic proteins may escape through cell membranes
damaged by mechanical scraping [3] and, as demon-
strated herein, through oncotic pores when cells or tis-
sues are gently washed with laboratory buffers, such as
PBS, or with isoosmotic serum-free media.
Conclusions
Oncotic release was identified as novel nonclassical
secretory pathway in which cytosolic proteins exit cells
through transient nonlethal oncotic pores in the plasma
membrane that form in response to the change in col-
loidal osmotic pressure upon serum withdrawal.
Methods
Materials
Minimal Essential Medium (MEM), newborn calf serum
(NCS), and glutamine were obtained from Invitrogen.
BFA was obtained from Epicentre Technologies. Calci-
mycin (A23187), cytochalasin D, EGTA, Exo1, glyburide,
methylamine, nocodazole, ouabain, and proteinase K
were obtained from Sigma. Bovine serum albumin
(BSA) (Fraction V) was obtained from Roche. Wheat
germ agglutinin (WGA), Alexa Fluor 488 goat anti-rab-
bit IgG, and SYTOX Green were obtained from Molecu-
lar Probes. AffiniPure Goat-Rabbit IgG (Fc Fragment
Specific), Biotin-SP-Conjugated AffiniPure Donkey Anti-
Chicken IgY, and peroxidase-conjugated streptavidin
were purchased from Jackson ImmunoResearch. The
preparation of affinity purified rabbit and chicken anti-
human PGK1 antibodies was described previously [11].
Cell Culture
HeLa cells (CCL2) were obtained from ATCC. They
were grown in MEM containing 2 mM glutamine and
10% newborn bovine serum (NCS) at 37°C and 5% CO2.
HeLa cells were used from passages 3 to 10 within the
laboratory.
Buffers
MEM Lysis Buffer was prepared by mixing 20 ml of
MEM, 1.1 ml of Triton X-100 (23.4% in PBS), and 1.1
ml of BSA/PIC. BSA/PIC was prepared by dissolving 1
tablet of complete Mini EDTA-free protease inhibitor
cocktail (Roche) in 5 ml of 2 mg/ml BSA in PBS.
PGK1 Release Assay
HeLa cells were plated at a density of 40,000 cells/well
of Nunc 4-well multi dish in 0.5 ml of MEM containing
with 2 mM glutamine and 10% NCS unless otherwise
stated. After 24 h, media was removed, the cells were
washed once with 0.5 ml of serum-free MEM containing
2 mM glutamine, and then incubated with the same
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for washing and capturing released proteins was prein-
cubated overnight at 37°C and 5% CO2. During manipu-
lations, culture dishes were placed on a Styrofoam
platform to minimize temperature changes and dishes
were processed individually. At different times the
media was transferred to a 1.5 ml microfuge tube con-
taining 27.8 μl of BSA/PIC on ice. BSA was added to
the microfuge tube to reduce potential nonspecific
adsorption of released proteins and to stabilize LDH
activity. Adherent cells were treated with 555 μlo f
MEM Lysis Buffer for 45 min at room temperature and
then the lysates were kept at 4°C until assayed. The
media fraction was centrifuged at 13,000 rpm for 2 min
at 4°C to remove any dislodged cells. The upper portion
of the supernatant (422 μl) was carefully transferred to a
fresh microfuge tube containing 22.2 μl of Triton X-100
(23.4% in PBS). Thus, the final composition of the
media fraction was equivalent to that of the MEM Lysis
Buffer.
The effect of a variety of inhibitors of the classical and
nonclassical secretory pathways on PGK1 release was
examined. The minimum effective dose (MED) was
determined for each inhibitor (data not shown). HeLa
cell cultures were preincubated separately with each
inhibitor at its MED for 30 min before starting the
release assay described above. The same inhibitor con-
centration was used during preincubation, wash, and
release. The inhibitors used were BFA (10 μM), Exo1
(50 μM), glyburide (100 μM), cytochalasin D (2 μM),
nocodazole (10 μM ) ,m e t h y l a m i n e( 5 0m M ) ,o u a b a i n
(100 μM), calcimycin (5 μM), and EGTA (5 mM). The
change in the amount of PGK1 and LDH in the media
and cell lysates was expressed as percent change within
each fraction (media or cell lysate) relative to fractions
from control cells treated with an equivalent amount of
vehicle.
PGK1 ELISA
The amount of PGK1 in media and cell lysates was
quantified using a sandwich ELISA as previously
described [11] with the following modifications to
increase sensitivity. The ELISA plate was coated with
AffiniPure Goat-Rabbit IgG, Fc Fragment Specific.
PGK1 was captured using affinity purified rabbit anti-
human PGK1 antibody [11]. PGK1 was detected using
the sequential application of affinity purified chicken
anti-human PGK1 antibody [11], biotin-SP-conjugated
AffiniPure donkey anti-chicken IgY, and peroxidase-con-
jugated streptavidin.
Lactate Dehydrogenase Assay (LDH)
The activity of LDH in media and cell lysates was mea-
sured using the CytoTox 96 Non Radioactive
Cytotoxicity Assay (Promega). A standard curve using
LDH provided by the manufacturer was done for each
experiment in MEM Lysis Buffer. Fractions (media and
cell lysates) were kept at 4°C and LDH activity was mea-
sured immediately after each experiment.
Sytox Green Assay
HeLa cells (14,000 cells/well) were incubated in MEM/
10% NCS at 37°C and 5% CO2 in a 96-well white plates
(Nunc). After 24 h, cells were left untreated or washed
once with serum-free MEM and then incubated with
the same media for 1 h. A parallel set of samples was
treated with water instead of serum-free MEM. At the
end of the incubation period, the media (or water) was
removed and the cells treated with 100 μlo fe t h a n o l :
acetone (1:1) for 10 min. The ethanol/acetone mixture
was removed and the samples were treated with 100 μl
of PBS for 10 min. The PBS was removed and the sam-
ples incubated with 100 μlo f1 2 5n MS y t o xG r e e ni n
PBS for 30 min. The fluorescence emission was mea-
sured using a Victor
3 1420 Multicolor Fluorescence
Plate Reader (Perkin Elmer).
Protease Protection Assay
HeLa cells were grown under the standard conditions
described above for monitoring PGK1 release. After 24
h, cells were washed once with serum-free MEM and
then incubated for 7.5 min in the same media at 37°C
and 5% CO2. The media was transferred into a 1.5 ml
microfuge tube and then centrifuged for 2 min at 4°C.
The supernatant was transferred to a fresh tube and
stored on ice. Aliquots (120 μl) of the supernatant were
treated with 4 μl of either proteinase K (10 mg/ml in 50
mM Tris-HCl, pH 8, 10 mM CaCl2)o rb u f f e ra l o n ei n
the presence or absence of a final concentration of 1%
Triton X-100. After the samples were incubated for 2 h
at 25°C, an aliquot was removed, mixed with an equal
volume of 2X SDS-PAGE sample buffer containing
DTT, and the mixture boiled for 5 min. Equivalent
volumes were separated on 12% SDS-PAGE gels [50]
a n di m m u n o b l o t t e d[ 5 0 ]w i t hr a b b i ta n t i - P G K 1
antibody.
Confocal Microscopy
HeLa cells were grown on polylysine coated coverslips
in MEM containing 10% NCS. After 24 h, they were
washed once with serum-free MEM and then incubated
with 0.5 ml of the same media for 30 min at 37°C and
5% CO2. Two controls were included in the experiment.
In the unperturbed control, a HeLa cell culture was
placed on ice, the media was removed by aspiration, and
the cells were fixed. In the oncotically matched control,
a culture was washed once with serum-free MEM con-
taining 6 mg/ml BSA, and then incubated with the same
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MEM and the serum-free MEM containing BSA used
for washing and incubating cells were preincubated at
37°C/5% CO2 and removed from the incubator just
before use. At the end of the incubation, the culture
dishes were placed on ice, the media removed by aspira-
tion, and the cells treated with 0.5 ml of ice-cold fixative
for 30 min on ice. The fixative was 0.25% paraformalde-
hyde, 0.0125% glutaraldehyde, and 250 mM sucrose in
MEM, pH 7.5. The components of the fixative were
optimized to preserve the integrity of the cell mem-
brane. After fixation, the cells were washed with PBS
and then blocked for 1 h with 3% BSA/1% goat serum
in PBS. To detect components at the cell surface, the
cells were incubated briefly (15 min) with affinity puri-
fied rabbit anti-human PGK1 antibody (1/500, [11]) and
Alexa Red conjugated WGA (1/500, Molecular Probes)
on ice. Alexa Green conjugated anti-rabbit antibody (1/
500) was used as a secondary antibody. Antibodies and
WGA were diluted with blocking solution. No deter-
gents were used during the preparation of cells for con-
focal microscopy. Images were acquired using BioRad
Radiance 2000 Confocal Laser Scanning Microscope
equipped with Plan NEOFLUAR 40X/1.30 Oil DIC
objective and LaserSharp 2000 software.
Statistical Analysis
Statistical significance between two sets of data was
determined using an unpaired t test. P < 0.05 was con-
sidered significant.
Additional material
Additional file 1: Table S1 contains the results of experiments using
additional inhibitors of PGK1 release.
Additional file 2: Figure S1 demonstrates that SYTOX Green can
enter HeLa cells under serum-free conditions.
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